Page 121 - 《中国药房》2022年12期
P. 121

[46]  KUSUHARA H,ITO S,KUMAGAI Y,et al. Effects of a    tinal flora on the pharmacokinetics and pharmacodyna-
             MATE protein inhibitor,pyrimethamine,on the renal  mics of aspirin in high-altitude hypoxia[J]. PLoS One,
             elimination of metformin at oral microdose and at therapeutic  2020,15(3):e0230197.
             dose in healthy subjects[J]. Clin Pharmacol Ther,2011,89  [61]  靳婷,罗冰峰,张晓云,等.缺氧对大鼠6种药物转运体基
            (6):837-844.                                        因表达影响的差异性研究[J].解放军药学学报,2017,33
        [47]  REN J X,ZHOU Y,ZHANG G Q,et al. Role of age-rela-  (4):297-301.
             ted decrease of renal organic cation transporter 2 in the  [62]  WOJTAL K A,CEE A,LANG S,et al. Downregulation of
             effect of atenolol on renal excretion of metformin in rats[J].  duodenal SLC transporters and activation of proinflamma-
             Eur J Drug Metab Pharmacokinet,2015,40(3):349-354.  tory signaling constitute the early response to high altitude
        [48]  MA Y R,SHI A X,QIN H Y,et al. Metoprolol decreases  in humans[J]. Am J Physiol Gastrointest Liver Physiol,
             the plasma exposure of metformin via the induction of  2014,307(7):G673-G688.
             liver,kidney and muscle uptake in rats[J]. Biopharm Drug  [63]  DUONG J K,ROBERTS D M,FURLONG T J,et al. Met-
             Dispos,2016,37(9):511-521.                         formin therapy in patients with chronic kidney disease[J].
        [49]  MINEMATSU T,GIACOMINI K M. Interactions of tyro-  Diabetes Obes Metab,2012,14(10):963-965.
             sine kinase inhibitors with organic cation transporters and  [64]  SMITH F C,KUMAR S S,FURLONG T J,et al. Pharma-
             multidrug and toxic compound extrusion proteins[J]. Mol  cokinetics of metformin in patients receiving regular he-
             Cancer Ther,2011,10(3):531-539.                    modiafiltration[J]. Am J Kidney Dis,2016,68(6):990-
        [50]  WU H,ESTEVE E,TREMAROLI V,et al. Metformin al-    992.
             ters the gut microbiome of individuals with treatment-  [65]  SINNAPPAH K A,KUAN I H S,THYNNE T R J,et al.
             naive type 2 diabetes,contributing to the therapeutic  The pharmacokinetics of metformin in patients receiving
             effects of the drug[J]. Nat Med,2017,23(7):850-858.  intermittent haemodialysis[J]. Br J Clin Pharmacol,2020,
        [51]  LEE C B,CHAE S U,JO S J,et al. The relationship be-  86(7):1430-1443.
             tween the gut microbiome and metformin as a key for  [66]  LI L,GUAN Z W,LI R,et al. Population pharmacokine-
             treating type 2 diabetes mellitus[J]. Int J Mol Sci,2021,22  tics and dosing optimization of metformin in Chinese
            (7):3566.                                           patients with type 2 diabetes mellitus[J]. Medicine,2020,
        [52]  王琰,蒋建东.肠道菌介导的PK-PD新模式:小檗碱药代                       99(46):e23212.
             动力学引发的思考[J].药学学报,2018,53(5):659-666.          [67]  RHEE S J,CHUNG H,YI S,et al. Physiologically based
        [53]  WU B,CHEN M Y,GAO Y C,et al. In vivo pharmacody-  pharmacokinetic modelling and prediction of metformin
             namic and pharmacokinetic effects of metformin mediated  pharmacokinetics in renal/hepatic-impaired young adults
             by the gut microbiota in rats[J]. Life Sci,2019,226:185-  and elderly populations[J]. Eur J Drug Metab Pharmacoki-
             192.                                               net,2017,42(6):973-980.
        [54]  黄隆基.高原低氧环境下常用降糖药物药代动力学特征                     [68]  SMITH F C,STOCKER S L,DANTA M,et al. The safety
             及其影响因素的研究[D].兰州:兰州大学,2021.                         and pharmacokinetics of metformin in patients with chro-
        [55]  KUNO T,HIRAYAMA-KUROGI M,ITO S,et al. Effect      nic liver disease[J]. Aliment Pharmacol Ther,2020,51
             of intestinal flora on protein expression of drug-metaboli-  (5):565-575.
             zing enzymes and transporters in the liver and kidney of  [69]  秦红岩,段好刚,魏玉辉,等.盐酸二甲双胍在正常大鼠与
             germ-free and antibiotics-treated mice[J]. Mol Pharm,  糖尿病大鼠体内的药动学比较[J].中国现代应用药学,
             2016,13(8):2691-2701.                              2009,26(6):433-436.
        [56]  LYU Y F,ZHANG Y F,YANG M B,et al. Pharmacokine-  [70]  SAMBOL N C,CHIANG J,O’CONNER M,et al. Phar-
             tic interactions between metformin and berberine in rats:  macokinetics and pharmacodynamics of metformin in
             role of oral administration sequences and microbiota[J].  healthy subjects and patients with noninsulin-dependent
             Life Sci,2019,235:116818.                          diabetes mellitus[J]. J Clin Pharmacol,1996,36(11):
        [57]  年永琼.模拟高原低氧对盐酸二甲双胍和对乙酰氨基酚                          1012-1021.
             药代动力学特征的影响[D].西宁:青海大学,2019.                   [71]  LIAO M Z,FLOOD NICHOLS S K,AHMED M,et al.
        [58]  罗冰峰,张俊,杨涛,等.高原急性缺氧对大鼠药物转运体                        Effects of pregnancy on the pharmacokinetics of metfor-
             PEPT1 及阿莫西林药代动力学的影响[J].药学学报,                       min[J]. Drug Metab Dispos,2020,48(4):264-271.
             2017,52(11):1715-1721.                        [72]  CHEN M H,YOU G Q,XIE C,et al. Pharmacokinetics of
        [59]  王昌,贾正平,李文斌,等. UFLC-MS/MS 法测定急进高                   metformin in collagen-induced arthritis rats[J]. Biochem
             原前后大鼠体内左氧氟沙星含量及其药代动力学差异[J].                        Pharmacol,2021,185:114413.
             华中科技大学学报(医学版),2017,46(2):160-164.                            (收稿日期:2021-09-15  修回日期:2022-04-27)
        [60]  SUN Y M,ZHANG J H,ZHAO A P,et al. Effects of intes-                               (编辑:孙    冰)


        中国药房    2022年第33卷第12期                                            China Pharmacy 2022 Vol. 33 No. 12  ·1519 ·
   116   117   118   119   120   121   122   123   124   125   126